questionsmedicales.fr
Actions chimiques et utilisations
Actions pharmacologiques
Effets physiologiques des médicaments
Agents neuromédiateurs
Agents cholinergiques
Inhibiteurs de la libération d'acétylcholine
Inhibiteurs de la libération d'acétylcholine : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Diagnostic
Acétylcholine
Neurologie
Tests électromyographiques
Acétylcholine
Analyse sanguine
Faiblesse musculaire
Fatigue
Acétylcholine
Antécédents médicaux
Acétylcholine
Évaluation clinique
Imagerie cérébrale
Pathologies neurologiques
Acétylcholine
Symptômes
5
Faiblesse musculaire
Fatigue
Coordination
Troubles de la mémoire
Concentration
Acétylcholine
Difficultés respiratoires
Acétylcholine
Système respiratoire
Âge
Symptômes
Acétylcholine
Nausées
Troubles gastro-intestinaux
Acétylcholine
Prévention
5
Prévention
Mode de vie sain
Acétylcholine
Alimentation équilibrée
Antioxydants
Acétylcholine
Exercice physique
Fonction musculaire
Acétylcholine
Stress
Symptômes
Acétylcholine
Contrôles réguliers
Surveillance
Acétylcholine
Traitements
5
Médicaments anticholinestérasiques
Thérapies physiques
Acétylcholine
Efficacité des traitements
Qualité de vie
Acétylcholine
Effets secondaires
Nausées
Acétylcholine
Rééducation physique
Renforcement musculaire
Acétylcholine
Traitements personnalisés
Acétylcholine
Médecine personnalisée
Complications
5
Complications
Troubles respiratoires
Crises musculaires
Hospitalisations
Surveillance
Acétylcholine
Risque de décès
Inhibition sévère
Acétylcholine
Complications réversibles
Traitement approprié
Acétylcholine
Gestion des complications
Approche multidisciplinaire
Acétylcholine
Facteurs de risque
5
Facteurs de risque
Maladies auto-immunes
Antécédents familiaux
Âge avancé
Facteurs de risque
Acétylcholine
Médicaments
Risque
Acétylcholine
Mode de vie sédentaire
Mauvaise alimentation
Acétylcholine
Infections virales
Risque
Acétylcholine
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Inhibiteurs de la libération d'acétylcholine : Questions médicales les plus fréquentes",
"headline": "Inhibiteurs de la libération d'acétylcholine : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Inhibiteurs de la libération d'acétylcholine : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-06",
"dateModified": "2025-05-01",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Inhibiteurs de la libération d'acétylcholine"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Agents cholinergiques",
"url": "https://questionsmedicales.fr/mesh/D018678",
"about": {
"@type": "MedicalCondition",
"name": "Agents cholinergiques",
"code": {
"@type": "MedicalCode",
"code": "D018678",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.696.577.120"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Inhibiteurs de la libération d'acétylcholine",
"alternateName": "Acetylcholine Release Inhibitors",
"code": {
"@type": "MedicalCode",
"code": "D065087",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Ikunobu Muramatsu",
"url": "https://questionsmedicales.fr/author/Ikunobu%20Muramatsu",
"affiliation": {
"@type": "Organization",
"name": "Department of Pharmacology, School of Medicine, Kanazawa Medical University, Uchinada, Ishikawa, Japan."
}
},
{
"@type": "Person",
"name": "Junsuke Uwada",
"url": "https://questionsmedicales.fr/author/Junsuke%20Uwada",
"affiliation": {
"@type": "Organization",
"name": "Department of Pharmacology, School of Medicine, Kanazawa Medical University, Uchinada, Ishikawa, Japan."
}
},
{
"@type": "Person",
"name": "Kiyonao Sada",
"url": "https://questionsmedicales.fr/author/Kiyonao%20Sada",
"affiliation": {
"@type": "Organization",
"name": "Division of Genomic Science and Microbiology, School of Medicine, University of Fukui, Eiheiji, Fukui, Japan."
}
},
{
"@type": "Person",
"name": "Takayoshi Masuoka",
"url": "https://questionsmedicales.fr/author/Takayoshi%20Masuoka",
"affiliation": {
"@type": "Organization",
"name": "Department of Pharmacology, School of Medicine, Kanazawa Medical University, Uchinada, Ishikawa, Japan."
}
},
{
"@type": "Person",
"name": "Takashi Yazawa",
"url": "https://questionsmedicales.fr/author/Takashi%20Yazawa",
"affiliation": {
"@type": "Organization",
"name": "Division of Cellular Signal Transduction, Department of Biochemistry, Asahikawa Medical University, Asahikawa, Hokkaido, Japan."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Radical mediastinal lipectomy for tamponade-like cardiac physiology.",
"datePublished": "2023-11-22",
"url": "https://questionsmedicales.fr/article/37990270",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s13019-023-02421-z"
}
},
{
"@type": "ScholarlyArticle",
"name": "Suprapubic Lipectomy and Placement of a Three-piece Inflatable Penile Prosthesis.",
"datePublished": "2023-08-05",
"url": "https://questionsmedicales.fr/article/37549696",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.urology.2023.07.029"
}
},
{
"@type": "ScholarlyArticle",
"name": "A Case Series of Lymphatic Injuries After Suction Lipectomy in Women with Lipedema.",
"datePublished": "2022-07-11",
"url": "https://questionsmedicales.fr/article/35811389",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.12659/AJCR.935016"
}
},
{
"@type": "ScholarlyArticle",
"name": "Incidence of Complications Associated With Lipectomy Techniques and Patient Body Mass Index: An Institutional and National Analysis Using the Tracking Operations and Outcomes for Plastic Surgeons.",
"datePublished": "2023-03-08",
"url": "https://questionsmedicales.fr/article/36921329",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/SAP.0000000000003532"
}
},
{
"@type": "ScholarlyArticle",
"name": "Lymphatic Improvement after Suction-assisted Lipectomy in a Lipedema Patient.",
"datePublished": "2023-06-21",
"url": "https://questionsmedicales.fr/article/37351118",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/GOX.0000000000005097"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Actions chimiques et utilisations",
"item": "https://questionsmedicales.fr/mesh/D020164"
},
{
"@type": "ListItem",
"position": 3,
"name": "Actions pharmacologiques",
"item": "https://questionsmedicales.fr/mesh/D020228"
},
{
"@type": "ListItem",
"position": 4,
"name": "Effets physiologiques des médicaments",
"item": "https://questionsmedicales.fr/mesh/D045505"
},
{
"@type": "ListItem",
"position": 5,
"name": "Agents neuromédiateurs",
"item": "https://questionsmedicales.fr/mesh/D018377"
},
{
"@type": "ListItem",
"position": 6,
"name": "Agents cholinergiques",
"item": "https://questionsmedicales.fr/mesh/D018678"
},
{
"@type": "ListItem",
"position": 7,
"name": "Inhibiteurs de la libération d'acétylcholine",
"item": "https://questionsmedicales.fr/mesh/D065087"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Inhibiteurs de la libération d'acétylcholine - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Inhibiteurs de la libération d'acétylcholine",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-18",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Inhibiteurs de la libération d'acétylcholine",
"description": "Comment diagnostiquer une inhibition de l'acétylcholine ?\nQuels tests sont utilisés pour évaluer l'acétylcholine ?\nQuels symptômes indiquent une inhibition d'acétylcholine ?\nLes antécédents médicaux sont-ils importants ?\nPeut-on utiliser l'imagerie pour le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D065087?mesh_terms=Lipectomy#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Inhibiteurs de la libération d'acétylcholine",
"description": "Quels sont les symptômes courants d'une inhibition ?\nL'inhibition affecte-t-elle la cognition ?\nY a-t-il des symptômes respiratoires associés ?\nLes symptômes varient-ils selon l'âge ?\nPeut-on avoir des symptômes digestifs ?",
"url": "https://questionsmedicales.fr/mesh/D065087?mesh_terms=Lipectomy#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Inhibiteurs de la libération d'acétylcholine",
"description": "Peut-on prévenir l'inhibition d'acétylcholine ?\nL'alimentation joue-t-elle un rôle ?\nL'exercice physique est-il bénéfique ?\nLe stress peut-il aggraver l'inhibition ?\nDes contrôles réguliers sont-ils nécessaires ?",
"url": "https://questionsmedicales.fr/mesh/D065087?mesh_terms=Lipectomy#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Inhibiteurs de la libération d'acétylcholine",
"description": "Quels traitements sont disponibles pour l'inhibition ?\nLes traitements sont-ils efficaces ?\nY a-t-il des effets secondaires aux traitements ?\nLa rééducation est-elle recommandée ?\nLes traitements sont-ils personnalisés ?",
"url": "https://questionsmedicales.fr/mesh/D065087?mesh_terms=Lipectomy#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Inhibiteurs de la libération d'acétylcholine",
"description": "Quelles complications peuvent survenir ?\nL'inhibition peut-elle entraîner des hospitalisations ?\nY a-t-il un risque de décès ?\nLes complications sont-elles réversibles ?\nComment gérer les complications ?",
"url": "https://questionsmedicales.fr/mesh/D065087?mesh_terms=Lipectomy#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Inhibiteurs de la libération d'acétylcholine",
"description": "Quels sont les facteurs de risque d'inhibition ?\nL'âge est-il un facteur de risque ?\nLes médicaments peuvent-ils influencer le risque ?\nLe mode de vie affecte-t-il le risque ?\nLes infections virales sont-elles un risque ?",
"url": "https://questionsmedicales.fr/mesh/D065087?mesh_terms=Lipectomy#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une inhibition de l'acétylcholine ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests neurologiques et l'évaluation des symptômes cliniques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer l'acétylcholine ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests électromyographiques et des analyses sanguines peuvent être utilisés."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une inhibition d'acétylcholine ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme la faiblesse musculaire et la fatigue peuvent indiquer une inhibition."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux sont-ils importants ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les antécédents médicaux aident à identifier des causes potentielles d'inhibition."
}
},
{
"@type": "Question",
"name": "Peut-on utiliser l'imagerie pour le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'imagerie cérébrale peut aider à exclure d'autres pathologies neurologiques."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants d'une inhibition ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent faiblesse musculaire, fatigue, et troubles de la coordination."
}
},
{
"@type": "Question",
"name": "L'inhibition affecte-t-elle la cognition ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut entraîner des troubles de la mémoire et de la concentration."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes respiratoires associés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des difficultés respiratoires peuvent survenir en cas d'inhibition sévère."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'âge ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent être plus prononcés chez les personnes âgées."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des symptômes digestifs ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des nausées et des troubles gastro-intestinaux peuvent se manifester."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir l'inhibition d'acétylcholine ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines mesures préventives incluent un mode de vie sain et la gestion du stress."
}
},
{
"@type": "Question",
"name": "L'alimentation joue-t-elle un rôle ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation équilibrée riche en antioxydants peut soutenir la santé neuronale."
}
},
{
"@type": "Question",
"name": "L'exercice physique est-il bénéfique ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier peut améliorer la fonction musculaire et nerveuse."
}
},
{
"@type": "Question",
"name": "Le stress peut-il aggraver l'inhibition ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut exacerber les symptômes d'inhibition d'acétylcholine."
}
},
{
"@type": "Question",
"name": "Des contrôles réguliers sont-ils nécessaires ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des contrôles réguliers permettent de surveiller l'évolution et d'ajuster les traitements."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour l'inhibition ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des médicaments anticholinestérasiques et des thérapies physiques."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils efficaces ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent améliorer les symptômes et la qualité de vie des patients."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets secondaires aux traitements ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des effets secondaires comme des nausées et des crampes peuvent survenir."
}
},
{
"@type": "Question",
"name": "La rééducation est-elle recommandée ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la rééducation physique peut aider à renforcer les muscles et améliorer la fonction."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils personnalisés ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements sont souvent adaptés en fonction des besoins individuels du patient."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des troubles respiratoires et des crises musculaires."
}
},
{
"@type": "Question",
"name": "L'inhibition peut-elle entraîner des hospitalisations ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des cas graves peuvent nécessiter une hospitalisation pour surveillance."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque de décès ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Dans des cas extrêmes, l'inhibition sévère peut entraîner des risques mortels."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être réversibles avec un traitement approprié."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion des complications nécessite une approche multidisciplinaire et un suivi régulier."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque d'inhibition ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des maladies auto-immunes, des infections et des antécédents familiaux."
}
},
{
"@type": "Question",
"name": "L'âge est-il un facteur de risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'âge avancé est un facteur de risque pour les troubles de la libération d'acétylcholine."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils influencer le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments peuvent augmenter le risque d'inhibition d'acétylcholine."
}
},
{
"@type": "Question",
"name": "Le mode de vie affecte-t-il le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire et une mauvaise alimentation peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Les infections virales sont-elles un risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines infections virales peuvent déclencher des troubles de la libération d'acétylcholine."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 01/05/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
Department of Pharmacology, School of Medicine, Kanazawa Medical University, Uchinada, Ishikawa, Japan.
Division of Genomic Science and Microbiology, School of Medicine, University of Fukui, Eiheiji, Fukui, Japan.
Kimura Hospital, Awara, Fukui, Japan.
Publications dans "Inhibiteurs de la libération d'acétylcholine" :
3 publications dans cette catégorie
Affiliations :
Department of Pharmacology, School of Medicine, Kanazawa Medical University, Uchinada, Ishikawa, Japan.
Division of Cellular Signal Transduction, Department of Biochemistry, Asahikawa Medical University, Asahikawa, Hokkaido, Japan.
Publications dans "Inhibiteurs de la libération d'acétylcholine" :
3 publications dans cette catégorie
Affiliations :
Division of Genomic Science and Microbiology, School of Medicine, University of Fukui, Eiheiji, Fukui, Japan.
Publications dans "Inhibiteurs de la libération d'acétylcholine" :
3 publications dans cette catégorie
Affiliations :
Department of Pharmacology, School of Medicine, Kanazawa Medical University, Uchinada, Ishikawa, Japan.
Publications dans "Inhibiteurs de la libération d'acétylcholine" :
2 publications dans cette catégorie
Affiliations :
Division of Cellular Signal Transduction, Department of Biochemistry, Asahikawa Medical University, Asahikawa, Hokkaido, Japan.
Publications dans "Inhibiteurs de la libération d'acétylcholine" :
2 publications dans cette catégorie
Affiliations :
Division of Cellular Signal Transduction, Department of Biochemistry, Asahikawa Medical University, Asahikawa, Hokkaido, Japan.
Publications dans "Inhibiteurs de la libération d'acétylcholine" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmacology, School of Medicine, Kanazawa Medical University, Uchinada, Ishikawa, Japan.
Publications dans "Inhibiteurs de la libération d'acétylcholine" :
2 publications dans cette catégorie
Affiliations :
Department of Clinical Pharmacology, School of Medicine, Tokai University, Isehara 259-1193, Japan.
Publications dans "Inhibiteurs de la libération d'acétylcholine" :
2 publications dans cette catégorie
Affiliations :
Tokyo Dental College, Misaki-cho, Chiyoda-ku, Tokyo 101-0061, Japan.
Publications dans "Inhibiteurs de la libération d'acétylcholine" :
2 publications dans cette catégorie
Affiliations :
Department of Molecular Neuroimmune Signaling, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia (D.S.L., E.V.K., I.A.I., N.S.E., N.D.T., E.N.S., E.Y.T., A.E.S., D.S.K., I.E.K., V.I.T.); Department of Neurobiology, Hellenic Pasteur Institute, Athens, Greece (M.Z., S.J.T.); Institute of Molecular Medicine, Sechenov First Moscow State Medical University, Moscow, Russia (I.E.K.); Institute of Chemistry and Molecular Engineering, Agricultural University of Georgia, Kakha Bendukidze University Campus, Tbilisi, Georgia (R.K., N.Z., I.I.); and PhysBio of MePhI, Moscow, Russia (V.I.T.) victortsetlin3f@gmail.com.
Publications dans "Inhibiteurs de la libération d'acétylcholine" :
2 publications dans cette catégorie
Affiliations :
Department of Cardiovascular Dynamics, National Cerebral and Cardiovascular Center, Osaka 564-8565, Japan. Electronic address: torukawa@ncvc.go.jp.
Publications dans "Inhibiteurs de la libération d'acétylcholine" :
2 publications dans cette catégorie
Affiliations :
Department of Cardiac Physiology, National Cerebral and Cardiovascular Center, Osaka 564-8565, Japan.
Publications dans "Inhibiteurs de la libération d'acétylcholine" :
2 publications dans cette catégorie
Affiliations :
Department of Cardiac Physiology, National Cerebral and Cardiovascular Center, Osaka 564-8565, Japan.
Publications dans "Inhibiteurs de la libération d'acétylcholine" :
2 publications dans cette catégorie
Affiliations :
Department of Cardiac Physiology, National Cerebral and Cardiovascular Center, Osaka 564-8565, Japan.
Publications dans "Inhibiteurs de la libération d'acétylcholine" :
2 publications dans cette catégorie
Affiliations :
Department of Cardiovascular Dynamics, National Cerebral and Cardiovascular Center, Osaka 564-8565, Japan.
Publications dans "Inhibiteurs de la libération d'acétylcholine" :
2 publications dans cette catégorie
Affiliations :
Kazan Institute of Biochemistry and Biophysics FRC Kazan Scientific Center of RAS, PB 30, Kazan 420111, Russia. Electronic address: ellyab@mail.ru.
Publications dans "Inhibiteurs de la libération d'acétylcholine" :
2 publications dans cette catégorie
Affiliations :
Department of Physiology and Pharmacology, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
Publications dans "Inhibiteurs de la libération d'acétylcholine" :
2 publications dans cette catégorie
Affiliations :
Department of Physiology and Pharmacology, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
Publications dans "Inhibiteurs de la libération d'acétylcholine" :
2 publications dans cette catégorie
Affiliations :
a Department of Pharmacy , Peking University People's Hospital , Beijing 100730 , China.
Publications dans "Inhibiteurs de la libération d'acétylcholine" :
2 publications dans cette catégorie
Affiliations :
b Beijing Key Laboratory of Drug Clinical Risk and Personalized Medication Evaluation, Department of Clinical Pharmacology , Beijing Hospital , Bejing 100044 , China.
Publications dans "Inhibiteurs de la libération d'acétylcholine" :
Re-opening the chest is an unwanted and potentially morbid complication after open heart surgery, most commonly required for refractory bleeding or tamponade. In this report, we present a unique case ...
A 62 year-old male presented to hospital with exertional angina and a coronary angiogram found severe three-vessel coronary artery disease with preserved left ventricular function. He underwent an unc...
To our knowledge, this case is the first reported occurrence of cardiac constriction from excessive mediastinal fat after open heart surgery. Identifying patients at high-risk for excessive pericardia...
Penile length loss is often observed in patients with erectile dysfunction and obesity. In patients with a prominent infrapubic fat pad, the excess fat can further reduce perceived penile length....
We retrospectively reviewed an institutional review board-approved prosthetic database of male patients that underwent placement of a 3-piece IPP and concurrent suprapubic lipectomy from 2020 to 2023....
Nine patients underwent the combined surgery. There were no intraoperative complications. In follow-up, 1 patient developed an infection-related complication that required device removal and immediate...
Concurrent suprapubic lipectomy and placement of a 3-piece IPP is a safe and reproducible technique for the treatment of suprapubic lipodystrophy, buried penis, and refractory ED....
BACKGROUND Lipedema is a loose connective tissue disease characterized by disproportionate subcutaneous adipose tissue hypertrophy in the extremities. There is evidence of impaired lymphatic function ...
An evaluation of complication rates in different abdominal lipectomy techniques with relationship to body mass index (BMI) and other risk factors....
We identified patients who underwent an abdominal lipectomy at our institution from January 2015 to July 2020. Those with concurrent hernia repair were excluded. Patients were classified into 2 groups...
At our institution, 362 patients (group 1 = 196, group 2 = 166) were included. A total of 40.9% of patients experienced at least one complication at 1 year postoperatively with the complication rate d...
The increasing complication rate within each BMI stratum of the large sample size of the TOPS patient cohort, in addition to our similar institutional trends, suggests that a staged procedure may be m...
Lipedema is a chronic and progressive disease that may compromise lymphatic function. Although suction-assisted lipectomy (SAL) is considered a safe treatment for lipedema patients, the lymphatic repe...
Madelung's disease is a rare disfiguring disorder that affects both function and esthetic appearance in the head and/or shoulder, neck, and arms regions. Lipectomy is typically necessary but such trea...
A prospective study and clinical descriptions were conducted on 17 patients undergoing 26 head-and-neck lipectomies. A tumescent solution was injected into the surgical region with a blunt-tip cannula...
All 17 male patients had a history of alcoholism. In total, 12 lipectomies for the removal of anterior neck fatty masses and 14 lipectomies for the removal of posterior neck fatty masses were performe...
Using tumescent solution in lipectomies to treat Madelung disease in the head and neck area is a simple, safe, and useful technique. The technique helps to create a clean operative field, reduces blee...
The preferred vascular access for hemodialysis is a native arteriovenous fistula (AVF) because it offers the best results in the short and long terms, lower morbidity and mortality, and has additional...
The authors review their experience with excision of subcutaneous tissue (lipectomy) overlying upper arm cephalic vein arteriovenous fistulas in obese patients....
Consecutive vascular access patients undergoing lipectomy for cannulation with difficult access because of vein depth were reviewed. Cephalic vein depth was measured by ultrasound in all cases....
Twenty-two patients were reviewed (15 men and 7 women), with a mean body mass index of 34.0 kg/m...
Obesity should not be a limiting factor to creation of a native AVF, since lipectomy is a relatively simple option for superficialization, enabling functioning native and deep arteriovenous fistulas i...
Abdominoplasty procedures continue to evolve as combining techniques such as suction-assisted lipectomy or direct sub-scarpal lipectomy have proven to be powerful adjuncts to achieve optimal aesthetic...
To assess the safety and efficacy of simultaneous direct sub-scarpal lipectomy combined with liposuction in abdominoplasty patients....
A 4-year retrospective review of consecutive abdominoplasties (n = 200) performed by a single surgeon was conducted. Liposuction of the abdominal flap and flanks was performed in all patients. After r...
Average values included: Age, 42.19; BMI, 28.10 kg/m2; follow up, 7 months. Seroma occurred in 13 patients (6.5%), superficial wound dehiscence treated with local wound care in 16 patients (8%), hyper...
Simultaneous direct excision of sub-scarpal fat with liposuction of the abdomen and flanks does not appear to subject any zone of the abdominoplasty flap to increased risks of vascular compromise. No ...
The epididymal fat is a type of gonadal adipose tissue, which is localized closely to the testis. Even though it has been suggested that the epididymal fat is necessary for maintenance of spermatogene...
Incorrect bispectral index (BIS) values have been reported due to interference with this monitoring system. We report a case of a 46-year-old woman who underwent liposuction and breast lipofilling, wh...